We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Roche Sues Ranbaxy Over Generic Antiviral Drug

Law360 (May 2, 2006, 12:00 AM EDT) -- California-based pharmaceutical company Roche Palo Alto LLC has filed a federal patent infringement lawsuit against Indian generics competitor Ranbaxy Laboratories Limited, in a move to protect the market for an antiviral drug.

The complaint, filed Friday in New Jersey’s District Court by Roche Palo Alto LLC, accuses Ranbaxy Laboratories Limited of infringing on a patent for valganciclovir hydrochloride, which is marketed by Roche as Valcyte.

Valcyte is an antiviral treatment, sometimes prescribed for an eye disease that takes root in AIDS patients.

On March 17, 2005...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.